Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist

NCT03218969 is registered in ClinicalTrials.gov with William Ondo, MD as lead sponsor.

NCT NCT03218969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03218969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
Lead sponsor
William Ondo, MD
Phase
Phase 1/2
Overall status
Completed
Start date
September 18, 2017
Completion date
November 28, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

augmentation, restless legs syndrome